Camporedondo, Rosabel A.
HRN: 21-40-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2022
CEFUROXIME 500MG (TAB)
05/22/2022
05/29/2022
PO
500mg
Bid
S/P NSD UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes